English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/152276
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

AutorEgea Maiquez, Javier; Fabregat, Isabel; López, Manuela G.; Cuadrado, Antonio ; Martínez-Ruiz, Antonio ; Miguel, Verónica ; Miranda-Vizuete, Antonio ; Monsalve, María ; Prieto, Ignacio; Lamas Peláez, Santiago ; Schmidt, Harald H.H.W.; Di Lisa, Fabio; Daiber, Andreas
Palabras claveReactive oxygen species
Reactive nitrogen species
Redox signaling
Oxidative stress
Antioxidants
Redox therapeutics
Fecha de publicación2017
EditorElsevier
CitaciónRedox Biology 13: 94-162 (2017)
ResumenThe European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed.
DescripciónReview article.-- et al.
Versión del editorhttp://dx.doi.org/10.1016/j.redox.2017.05.007
URIhttp://hdl.handle.net/10261/152276
DOI10.1016/j.redox.2017.05.007
ISSN2213-2317
10.1016/j.redox.2017.05.007
Aparece en las colecciones: (IIBM) Artículos
(IBIS) Artículos
(CBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
euro1203cost.pdf4,98 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.